4//SEC Filing
IMPAX LABORATORIES INC 4
Accession 0001003642-16-000020
CIK 0001003642operating
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 3:46 PM ET
Size
9.6 KB
Accession
0001003642-16-000020
Insider Transaction Report
Form 4
BENET LESLIE Z
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2016-08-15−20,000→ 30,000 totalExercise: $6.55Exp: 2019-05-20→ Common Stock (20,000 underlying) - Sale
Common Stock
2016-08-15$22.81/sh−10,092$230,199→ 30,133 total - Exercise/Conversion
Common Stock
2016-08-15$6.55/sh+20,000$131,000→ 40,225 total
Holdings
- 600(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold at prices ranging from $22.75 to $22.90 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]100% of the shares subject to the option are fully vested and exercisable.
Documents
Issuer
IMPAX LABORATORIES INC
CIK 0001003642
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001003642
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 3:46 PM ET
- Size
- 9.6 KB